We are live on ! Find out more
PROK icon

ProKidney

56 hedge funds and large institutions have $446M invested in ProKidney in 2023 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 20 increasing their positions, 3 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,225% more call options, than puts

Call options by funds: $106K | Put options by funds: $8K

567% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 3

350% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 6

60% more funds holding

Funds holding: 3556 (+21)

14% more capital invested

Capital invested by funds: $391M → $446M (+$54.4M)

8.48% more ownership

Funds ownership: 56.17%64.65% (+8.5%)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

Holders
56
Holders Change
+21
Holders Change %
+60%
% of All Funds
0.88%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
27
Increased
20
Reduced
3
Closed
6
Calls
$106K
Puts
$8K
Net Calls
+$98K
Net Calls Change
-$33K
Name Holding Trade Value Shares
Change
Change in
Stake
US Bancorp
51
US Bancorp
Minnesota
$23.5K +$18K +1,692 +414%
Citadel Advisors
52
Citadel Advisors
Florida
$10.1K +$9.58K +900 New
Fidelity Investments
53
Fidelity Investments
Massachusetts
$5.66K +$5.38K +505 New
S
54
SignatureFD
Georgia
$1.46K +$266 +25 +24%
Nisa Investment Advisors
55
Nisa Investment Advisors
Missouri
$481 +$458 +43 New
Osaic Holdings
56
Osaic Holdings
Arizona
$11
Millennium Management
57
Millennium Management
New York
-$1.16M -102,059 Closed
HF
58
HRT Financial
New York
-$730K -64,507 Closed
UOC
59
UBS O'Connor
Illinois
-$564K -49,782 Closed
Squarepoint
60
Squarepoint
New York
-$293K -25,883 Closed
ECM
61
ExodusPoint Capital Management
New York
-$151K -13,343 Closed
Tudor Investment Corp
62
Tudor Investment Corp
Connecticut
-$146K -12,917 Closed

PROK Hedge Fund Activity: Q2 2023 in Review

56 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in ProKidney (PROK) for Q2 2023, worth a combined $446M — up 14% from $391M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new PROK positions and 6 closed out — a net gain of 21 holders — while 20 added to existing stakes and 3 trimmed.

The largest buyer was BlackRock, adding an estimated $32M. The largest seller was Vanguard Group, cutting an estimated $11.6M.

  • 56 institutional investors held ProKidney (PROK) as of Q2 2023, up from 35 in Q1 2023.
  • Funds reported $446M of ProKidney stock for Q2 2023, up 14% quarter-over-quarter.
  • 27 funds opened new ProKidney positions in Q2 2023 and 6 closed out, a net change of +21 holders.
  • The largest ProKidney buyer in Q2 2023 was BlackRock, an estimated $32M added.
  • The largest ProKidney seller in Q2 2023 was Vanguard Group, an estimated $11.6M sold.

Based on aggregated 13F filings for Q2 2023.